Effectiveness of the HuCare Quality Improvement Strategy on health-related quality of life in patients with cancer: study protocol of a stepped-wedge cluster randomised controlled trial (HuCare2 study)

Caterina Caminiti, Elisa Iezzi, Rodolfo Passalacqua, Caterina Caminiti, Elisa Iezzi, Rodolfo Passalacqua

Abstract

Introduction: Our group previously demonstrated the feasibility of the HuCare Quality Improvement Strategy (HQIS), aimed at integrating into practice six psychosocial interventions recommended by international guidelines. This trial will assess whether the introduction of the strategy in oncology wards improves patient's health-related quality of life (HRQoL).

Methods and analysis: Multicentre, incomplete stepped-wedge cluster randomised controlled trial, conducted in three clusters of five centres each, in three equally spaced time epochs. The study also includes an initial epoch when none of the centres are exposed to the intervention, and a final epoch when all centres will have implemented the strategy. The intervention is applied at a cluster level, and assessed at an individual level with cross-sectional model. A total of 720 patients who received a cancer diagnosis in the previous 2 months and about to start medical treatment will be enrolled. The primary aim is to evaluate the effectiveness of the HQIS versus standard care in terms of improvement of at least one of two domains (emotional and social functions) of HRQoL using the EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items) questionnaire, at baseline and at 3 months. This outcome was chosen because patients with cancer generally exhibit low HRQoL, particularly at certain stages of care, and because it allows to assess the strategy's impact as perceived by patients themselves. The HQIS comprises three phases: (1) clinician training-to improve communication-relational skills and instruct on the project; (2) centre support-four on-site visits by experts of the project team, aimed to boost motivation, help with context analysis and identification of solutions; (3) implementation of Evidence-Based Medicine (EBM) recommendations at the centre.

Ethics and dissemination: Ethics committee review approval has been obtained from the Ethics Committee of Parma. Results will be disseminated at conferences, and in peer-reviewed and professional journals intended for policymakers and managers.

Trial registration number: NCT03008993; Pre-results.

Keywords: cancer patients; communication skills; health-related quality of life; implementation strategy; psychosocial interventions; stepped-wedge design.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Study design: stepped-wedge cluster randomised controlled trial (SWD-CRT). HQIS, HuCare Quality Improvement Strategy.
Figure 2
Figure 2
HuCare Quality Improvement Strategy (HQIS) flow chart.
Figure 3
Figure 3
Schedule of enrolment, interventions and assessments. HQIS, HuCare Quality Improvement Strategy.
Figure 4
Figure 4
Sample size per epoch and cluster.

References

    1. Howell D, Mayo S, Currie S, et al. . Canadian Association of Psychosocial Oncology (CAPO); Cancer Journey Action Group of the Canadian Partnership Against Cancer (CPAC). Psychosocial health care needs assessment of adult cancer patients: a consensus-based guideline. Support Care Cancer 2012;20:3343–54.
    1. Galway K, Black A, Cantwell M, et al. . Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Database Syst Rev 2012;11:CD007064 10.1002/14651858.CD007064.pub2
    1. Harrison JD, Young JM, Price MA, et al. . What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer 2009;17:1117–28. 10.1007/s00520-009-0615-5
    1. Bultz BD, Carlson LE. Emotional distress: the sixth vital sign-future directions in cancer care. Psychooncology 2006;15:93–5. 10.1002/pon.1022
    1. Holland J, Watson M, Dunn J. The IPOS new International Standard of Quality Cancer Care: integrating the psychosocial domain into routine care. Psychooncology 2011;20:677–80. 10.1002/pon.1978
    1. Jacobsen PB, Wagner LI. A new quality standard: the integration of psychosocial care into routine cancer care. J Clin Oncol 2012;30:1154–9. 10.1200/JCO.2011.39.5046
    1. Turner J. The changing landscape of cancer care - the impact of psychosocial clinical practice guidelines. Psychooncology 2015;24:365–70. 10.1002/pon.3803
    1. Bultz BD, Johansen C, distress S. The 6th vital sign: where are we and where are we going?. Psychooncology 2011;20:569–71.
    1. Jacobsen PB, Lee M. Integrating psychosocial care into routine cancer care. Cancer Control 2015;22:442–9. 10.1177/107327481502200410
    1. Travado L, Reis JC, Watson M, et al. . Psychosocial oncology care resources in Europe: a study under the European Partnership for Action Against Cancer (EPAAC). Psychooncology 2017;26 10.1002/pon.4044
    1. Schofield P, Carey M, Bonevski B, et al. . Barriers to the provision of evidence-based psychosocial care in oncology. Psychooncology 2006;15:863–72. 10.1002/pon.1017
    1. Dilworth S, Higgins I, Parker V, et al. . Patient and health professional’s perceived barriers to the delivery of psychosocial care to adults with cancer: a systematic review. Psychooncology 2014;23:601–12. 10.1002/pon.3474
    1. Hack TF, Carlson L, Butler L, et al. . Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive care. Support Care Cancer 2011;19:1097–105. 10.1007/s00520-011-1159-z
    1. Turner J, Kelly B, Clarke D, et al. . A randomised trial of a psychosocial intervention for cancer patients integrated into routine care: the PROMPT study (promoting optimal outcomes in mood through tailored psychosocial therapies). BMC Cancer 2011;11:48 10.1186/1471-2407-11-48
    1. Bosch M, van der Weijden T, Wensing M, et al. . Tailoring quality improvement interventions to identified barriers: a multiple case analysis. J Eval Clin Pract 2007;13:161–8. 10.1111/j.1365-2753.2006.00660.x
    1. Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer services. J Clin Oncol 2012;30:1178–86. 10.1200/JCO.2011.39.7398
    1. Williams KC, Brothers BM, Ryba MM, et al. . Implementing evidence-based psychological treatments for cancer patients. Psychooncology 2015;24:1618–25. 10.1002/pon.3937
    1. Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ 2008;337:a1714 10.1136/bmj.a1714
    1. Passalacqua R, Annunziata MA, Borreani C, et al. . Feasibility of a quality improvement strategy integrating psychosocial care into 28 medical cancer centers (HuCare project). Support Care Cancer 2016;24:147–55. 10.1007/s00520-015-2756-z
    1. Zwerver F, Schellart AJ, Anema JR, et al. . Changes in insurance physicians' attitudes, self-efficacy, intention, and knowledge and skills regarding the guidelines for depression, following an implementation strategy. J Occup Rehabil 2013;23:148–56. 10.1007/s10926-012-9378-9
    1. Ament SM, Gillissen F, Moser A, et al. . Identification of promising strategies to sustain improvements in hospital practice: a qualitative case study. BMC Health Serv Res 2014;14:641 10.1186/s12913-014-0641-y
    1. Roila F, Cortesi E. Quality of life as a primary end point in oncology. Ann Oncol 2001;12(Suppl 3):S3–6. 10.1093/annonc/12.suppl_3.S3
    1. Kenzik KM, Ganz PA, Martin MY, et al. . How much do cancer-related symptoms contribute to health-related quality of life in lung and colorectal cancer patients? A report from the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium. Cancer 2015;121:2831–9. 10.1002/cncr.29415
    1. Choi EP, Wong CK, Tsu JH, et al. . Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations. Support Care Cancer 2016;24:1849–56. 10.1007/s00520-015-2980-6
    1. Aro K, Bäck L, Loimu V, et al. . Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer. Eur Arch Otorhinolaryngol 2016;273:2141–50. 10.1007/s00405-015-3732-4
    1. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006;24:5132–7. 10.1200/JCO.2006.06.8775
    1. Basch E, Abernethy AP, Mullins CD, et al. . Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012;30:4249–55. 10.1200/JCO.2012.42.5967
    1. American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996;14:671–9.
    1. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 2003;21:1404–11. 10.1200/JCO.2003.08.072
    1. Hj A, Ringash J, Brundage M, et al. . NCIC CTG Quality of Life Committee. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. Expert Rev Pharmacoecon Outcomes Res 2010;10:119–28.
    1. Halyard MY, Ferrans CE. Quality-of-Life assessment for routine oncology clinical practice. J Support Oncol 2008;6:221–9.
    1. Bultz BD, Travado L, Jacobsen PB, et al. . 2014 President’s plenary international psycho-oncology society: moving toward cancer care for the whole patient. Psychooncology 2015;24:1587–93. 10.1002/pon.3844
    1. Borras JM, Albreht T, Audisio R, et al. . Policy statement on multidisciplinary cancer care. Eur J Cancer 2014;50:475–80. 10.1016/j.ejca.2013.11.012
    1. Craig P, Dieppe P, Macintyre S, et al. . Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
    1. The EQUATOR Network. Enhancing the QUAlity and Transparency Of Health Research. (accessed Dec 2016).
    1. Hemming K, Haines TP, Chilton PJ, et al. . The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ 2015;350:h391 10.1136/bmj.h391
    1. Hemming K, Lilford R, Girling AJ. Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs. Stat Med 2015;34:181–96. 10.1002/sim.6325
    1. Cocks K, King MT, Velikova G, et al. . Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer 2012;48:1713–21. 10.1016/j.ejca.2012.02.059
    1. Zhu L, Ranchor AV, van der Lee M, et al. . Subtypes of depression in cancer patients: an empirically driven approach. Support Care Cancer 2016;24:1387–96. 10.1007/s00520-015-2919-y
    1. Apolone G, Filiberti A, Cifani S, et al. . Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 1998;9:549–57. 10.1023/A:1008264412398
    1. Osoba D, Zee B, Pater J, et al. . Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994;3:353–64. 10.1007/BF00451727
    1. Cella DF, Tulsky DS, Gray G, et al. . The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570–9. 10.1200/JCO.1993.11.3.570
    1. Luckett T, King MT, Butow PN, et al. . Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 2011;22:2179–90. 10.1093/annonc/mdq721
    1. King MT, Bell ML, Costa D, et al. . The Quality of Life Questionnaire Core 30 (QLQ-C30) and Functional Assessment of Cancer-General (FACT-G) differ in responsiveness, relative efficiency, and therefore required sample size. J Clin Epidemiol 2014;67:100–7. 10.1016/j.jclinepi.2013.02.019
    1. Uwer L, Rotonda C, Guillemin F, et al. . Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes 2011;9:70 10.1186/1477-7525-9-70
    1. Pollom EL, Wang E, Bui TT, et al. . A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers. Oral Oncol 2015;51:1132–7. 10.1016/j.oraloncology.2015.10.003
    1. Kesterke N, Egeter J, Erhardt JB, et al. . Patient-reported outcome assessment after total joint replacement: comparison of questionnaire completion times on paper and tablet computer. Arch Orthop Trauma Surg 2015;135:935–41. 10.1007/s00402-015-2222-x
    1. Marcano Belisario JS, Jamsek J, Huckvale K, et al. . Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods. Cochrane Database Syst Rev 2015;7:MR000042.
    1. Berry DL, Blonquist TM, Patel RA, et al. . Exposure to a patient-centered, Web-based intervention for managing cancer symptom and quality of life issues: impact on symptom distress. J Med Internet Res 2015;17:e136 10.2196/jmir.4190
    1. Manuals EORTC. (accessed Dec 2016).
    1. Costantini M, Musso M, Viterbori P, et al. . Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer 1999;7:121–7. 10.1007/s005200050241
    1. Tamburini M, Gangeri L, Brunelli C, et al. . Assessment of hospitalised cancer patients' needs by the Needs Evaluation Questionnaire. Ann Oncol 2000;11:31–7. 10.1023/A:1008396930832
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007;28:182–91. 10.1016/j.cct.2006.05.007
    1. Hemming K, Girling A. The efficiency of stepped wedge vs. cluster randomized trials: Stepped wedge studies do not always require a smaller sample size. J Clin Epidemiol 2013;66:1427–8. 10.1016/j.jclinepi.2013.07.007
    1. Hemming K. Girling A. A menu-driven facility for power and detectable-difference calculations in stepped-wedge cluster-randomized trials. Stat J 2014;14:363–80.
    1. Hemming K, Taljaard M. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach. J Clin Epidemiol 2016;69:137–46. 10.1016/j.jclinepi.2015.08.015
    1. Cocks K, King MT, Velikova G, et al. . Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 2011;29:89–96. 10.1200/JCO.2010.28.0107
    1. Lundy JJ, Coons SJ, Aaronson NK. Testing the measurement equivalence of paper and interactive voice response system versions of the EORTC QLQ-C30. Qual Life Res 2014;23:229–37. 10.1007/s11136-013-0454-1
    1. Ledderer L, la Cour K, Mogensen O, et al. . Feasibility of a psychosocial rehabilitation intervention to enhance the involvement of relatives in cancer rehabilitation: pilot study for a randomized controlled trial. Patient 2013;6:201–12. 10.1007/s40271-013-0019-y
    1. Annunziata MA, Muzzatti B, Altoè G. Defining hospital anxiety and depression scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings. Ann Oncol 2011;22:2330–3. 10.1093/annonc/mdq750
    1. Vodermaier A, Millman RD. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 2011;19:1899–908. 10.1007/s00520-011-1251-4
    1. Arostegui I, Núñez-Antón V, Quintana JM. Statistical approaches to analyse patient-reported outcomes as response variables: an application to health-related quality of life. Stat Methods Med Res 2012;21:189–214. 10.1177/0962280210379079
    1. Khan I, Bashir Z, Forster M. Interpreting small treatment differences from quality of life data in cancer trials: an alternative measure of treatment benefit and effect size for the EORTC-QLQ-C30. Health Qual Life Outcomes 2015;13:180 10.1186/s12955-015-0374-6
    1. Fayers and Machin. Quality of Life:Assessment, Analysis and Interpretation. Chicester: J Wiley & Sons Ltd, 2000. ISBN: 0-471-96861-7.
    1. Abernethy AP, Herndon JE, Wheeler JL, et al. . Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology. J Pain Symptom Manage 2009;37:1027–38. 10.1016/j.jpainsymman.2008.07.011
    1. Mark TL, Fortner B, Johnson G. Evaluation of a tablet PC technology to screen and educate oncology patients. Supportive Care in Cancer 2008;16:371–8. 10.1007/s00520-007-0312-1
    1. Hoomans T, Ament AJHA, Evers SMAA, et al. . Implementing guidelines into clinical practice: what is the value? J Eval Clin Pract 2011;17:606–14. 10.1111/j.1365-2753.2010.01557.x
    1. Fallowfield L, Jenkins V, Farewell V, et al. . Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer 2003;89:1445–9. 10.1038/sj.bjc.6601309
    1. Kissane DW, Bylund CL, Banerjee SC, et al. . Communication skills training for oncology professionals. J Clin Oncol 2012;30:1242–7. 10.1200/JCO.2011.39.6184
    1. Moore PM, Rivera Mercado S, Grez Artigues M, et al. . Communication skills training for healthcare professionals working with people who have cancer. Cochrane Database Syst Rev 2013;3:CD003751 10.1002/14651858.CD003751.pub3
    1. Stiefel F, Barth J, Bensing J, et al. . Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Ann Oncol 2010;21:204–7. 10.1093/annonc/mdp564
    1. Barth J, Lannen P. Efficacy of communication skills training courses in oncology: a systematic review and meta-analysis. Ann Oncol 2011;22:1030–40. 10.1093/annonc/mdq441
    1. Brown RF, Bylund CL. Communication skills training: describing a new conceptual model. Acad Med 2008;83:37–44. 10.1097/ACM.0b013e31815c631e
    1. Dimoska A, Tattersall MHN, Butow PN, et al. . Can a “prompt list” empower cancer patients to ask relevant questions? Cancer 2008;113:225–37. 10.1002/cncr.23543
    1. Brandes K, Linn AJ, Butow PN, et al. . The characteristics and effectiveness of Question Prompt List interventions in oncology: a systematic review of the literature. Psychooncology 2015;24:245–52. 10.1002/pon.3637
    1. Caminiti C, Diodati F, Filiberti S, et al. . Cross-cultural adaptation and patients' judgments of a Question Prompt List for Italian-speaking cancer patients. BMC Health Serv Res 2010;10:16 10.1186/1472-6963-10-16
    1. Cruickshank S, Kennedy C, Lockhart K, et al. . Specialist breast care nurses for supportive care of women with breast cancer. Cochrane Database Syst Rev 2008;1:CD005634.
    1. Cook O, McIntyre M, Recoche K. Exploration of the role of specialist nurses in the care of women with gynaecological cancer: a systematic review. J Clin Nurs 2015;24:683–95. 10.1111/jocn.12675
    1. Pirl WF, Fann JR, Greer JA, et al. . Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer 2014;120:2946–54. 10.1002/cncr.28750
    1. Bultz BD, Travado L, Jacobsen PB, et al. . 2014 President’s plenary international psycho-oncology society: moving toward cancer care for the whole patient. Psychooncology 2015;24:1587–93. 10.1002/pon.3844
    1. Holland JC, Andersen B, Breitbart WS, et al. . Distress management. J Natl Compr Canc Netw 2010;8:448–85. 10.6004/jnccn.2010.0034
    1. Passalacqua R, Caminiti C, Campione F, et al. . Prospective, multicenter, randomized trial of a new organizational modality for providing information and support to cancer patients. J Clin Oncol 2009;27:1794–9. 10.1200/JCO.2007.15.0615

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa